Italia markets closed

TEVA Jul 2024 16.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1400+0,0300 (+27,27%)
In data: 03:35PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1100
Aperto0,0800
Denaro0,0800
Domanda0,3400
Prezzo d'esercizio16,00
Scadenza2024-07-05
Min-Max giorno0,0800 - 0,1400
Contratto - Min-MaxN/D
Volume38
Open Interest548
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.